Status:
UNKNOWN
Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Alcohol-related Liver Disease
Alcohol Dependence
Eligibility:
All Genders
18+ years
Brief Summary
The lockdown consequent to Coronavirus outbreak has had a differential impact on the drinking behaviour on the general population. The impact is unknown on the people with underlying chronic liver dis...
Detailed Description
ICoLD, is a collaborative study between the King's College Hospital and SLaM. This is an observational self-report questionnaire study. The study population will comprise of people with alcohol-relate...
Eligibility Criteria
Inclusion
- Age \>18 years.
- People with alcohol related Liver disease
Exclusion
- Patient lacks capacity to consent to the study, e.g. due to hepatic encephalopathy, alcohol-related brain damage, or pre-existing learning disability
- Aged \<18 years old
- Patients unable to understand English
- Patients being considered for liver transplant
Key Trial Info
Start Date :
October 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04876443
Start Date
October 8 2020
End Date
July 31 2022
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver Studies
London, United Kingdom, SE5 9RS